# The Liquid Embolic Agent for the Treatment of Brain Arteriovenous Malformation

> **NCT07314047** · NA · RECRUITING · sponsor: **MicroPort NeuroTech Co., Ltd.** · enrollment: 116 (estimated)

## Conditions studied

- Brain Arteriovenous Malformation
- Arteriovenous Fistula

## Interventions

- **DEVICE:** liquid embolic agent

## Key facts

- **NCT ID:** NCT07314047
- **Lead sponsor:** MicroPort NeuroTech Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-05-28
- **Primary completion:** 2025-05-28
- **Final completion:** 2026-05-28
- **Target enrollment:** 116 (ESTIMATED)
- **Last updated:** 2026-01-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07314047

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07314047, "The Liquid Embolic Agent for the Treatment of Brain Arteriovenous Malformation". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07314047. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*